Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

• Conditions: Incidence of Readmissions; ADE's Due to Anticoagulants

• Registration Number: NCT02074085
• Lead Sponsor: Hasselt University

Brief Summary

An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-02
• Study First Submitted: 2014-02-25
• Study First Submitted QC: 2014-02-25
• Last Update Submitted: 2014-02-25
• Study First Posted: 2014-02-28
• Last Update Posted: 2014-02-28
• Study Start: 2014-03
• Primary Completion: 2014-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 450

Inclusion Criteria

1. Patients who received an anticoagulant on their last day of admission
2. Patients who were readmitted within 30 days
3. Patients who were diagnosed using the pathology registration of the emergency department of the Jessa hospital

Exclusion Criteria

1. Patients who didn't receive an anticoagulant on their last day of admission
2. Patients who were not readmitted within 30 days
3. Patients who were not diagnosed using the pathology registration of the emergency department of the Jessa hospital
4. Patients with missing data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of readmissions within one week caused by ADE's due to anticoagulants	up to one week
incidence of readmissions within 30 days caused by ADE's due to anticoagulants	up to 1 month
incidence of preventable ADE's leading to readmission	week 1, month 1

Trial Locations

Locations (1)

Jessa Ziekenhuis; 🇧🇪 Hasselt, Belgium